Breast Cancer Tops List of Malpractice Claims

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 4 No 9
Volume 4
Issue 9

WASHINGTON--Breast cancer leads the list of diseases for which malpractice claims have been filed in the last decade, according to a study from the Physician Insurers Association of America. Of 117,000 claims filed since 1985, about 2,500 involved breast cancer.

WASHINGTON--Breast cancer leads the list of diseases for whichmalpractice claims have been filed in the last decade, accordingto a study from the Physician Insurers Association of America.Of 117,000 claims filed since 1985, about 2,500 involved breastcancer.

The association stressed that this number is small compared withthe estimated 1.5 million women who received a breast cancer diagnosisduring that period.

In an analysis of 487 delay in diagnosis claims, the average delaywas 14 months; 91% of these patients were under age 50. Although60% of these women found a lump by self-examination, in 35% ofcases, the "physical findings failed to impress the physician,"the study said, and this was the most common reason for delay.The second leading cause was failure to follow up on physicalexams and inconclusive mammograms.

Recent Videos
Administering oral SERD-based regimens may enhance patients’ quality of life when undergoing treatment for ER-positive, HER2-negative breast cancer.
Gedatolisib-based triplet regimens may be effective among patients with prior endocrine resistance or rapid progression following frontline therapy.
Leading experts in the breast cancer field highlight the use of CDK4/6 inhibitors, antibody-drug conjugates, and other treatment modalities.
Patients with node-negative disease who are older and have comorbidities may not be suitable to receive CDK4/6 inhibitors.
An observed carryover effect with CDK4/6 inhibitors may reduce the risk of recurrence years after a patient stops treatment.
Related Content